Analyst Price Target is $17.00
▲ +65.37% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Definitive Healthcare in the last 3 months. The average price target is $17.00, with a high forecast of $26.00 and a low forecast of $13.00. The average price target represents a 65.37% upside from the last price of $10.28.
Current Consensus is
Hold
The current consensus among 7 investment analysts is to hold stock in Definitive Healthcare. This rating has held steady since November 2022, when it changed from a Buy consensus rating.
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Read More